New Techniques in Assessing the Anatomy and Function of Atherosclerosis: Promises and Pitfalls

  • Peter Liu
Part of the Nato ASI Series book series (NSSA, volume 219)


Diseases that are the consequences of vascular atherosclerotic process still constitute the most important cause of mortality and morbidity in the Western world. Despite advances in the understanding of the disease process [1,2], our ability to assess the early presence, the anatomical extent and functional impact of atherosclerosis is still limited. The availability of new and better tools to assess atherosclerosis will provide us with means to monitor the effectiveness of preventive and therapeutic strategies. With the recent rapid advances in technology, many modalities are now available to permit us to assess atherosclerosis with different approaches. This paper will outline these general approaches, and will concentrate on two areas of endovascular ultrasound and new myocardial perfusion agents.


Myocardial Perfusion Atherosclerotic Plaque Coronary Atherosclerosis Calcify Plaque Nuclear Magnetic Resonance Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. Ross, The pathogenesis of atherosclerosis - An update, N Engl J Med. 314:488–500 (1986).PubMedCrossRefGoogle Scholar
  2. 2.
    D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum, Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:915–924 (1989).PubMedCrossRefGoogle Scholar
  3. 3.
    C.M. Gondin, I. Dydra, A. Pasternac, L. Campeau, M.G. Bourassa, and J. Lesperance. Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation 49:703–713 (1974).Google Scholar
  4. 4.
    D. D. McPherson, L.F. Hiratzka, W.C. Lamberth, B. Brandt, M. Hunt, R.A. Kieso, M.L. Marcus, and R.E. Kerber, Delineation of the extent of coronary athetsclerosis by high frequency epicardial echocardiography, N Engl J Med. 316:304–309 (1987).PubMedCrossRefGoogle Scholar
  5. 5.
    D.H. Blankenborn, S.A. Nessim, R.L. Johnson, M.E. Sanmarco, S.P. Azen, and L. Cashin-Hemphill, Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA. 257:3233–3240 (1987).CrossRefGoogle Scholar
  6. 6.
    B.C. Brown, J.T. Lin, S.M. Schaefer, C.A. Kaplan, H.T. Dodge, and J.J. Albers. Niacin or lovastatin, combined with colestipol, regress coronary atherosclerosis and prevent clinical events in men with elevated apolipoprotein. Circulation 80(11):266 (1989).Google Scholar
  7. 7.
    A. Loaldi, A. Polese, P. Montorsi, N. De Cesare, F. Fabbiocchi, P. Ravagnani, and M.D. Guazzi, Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris. Am J Cardiol. 64:433–43 (1989).PubMedCrossRefGoogle Scholar
  8. 8.
    J.S. Forrester, F. Litvack, W. Grundfest, and A. Hickey, A perspective of coronary disease seen through the arteries of living man. Circulation 3:505–513 (1987).CrossRefGoogle Scholar
  9. 9.
    C.T. Sherman, F. Litvack, W.S. Grundfest, M. Lee, A. Hickey, A. Chaux, R. Kass, C. Blanche, J. Matloff, L. Morgenstern, W. Ganz, H.J.C. Swan, and J. Forrester. Demonstration of thrombus and complex atheroma by in-vivo angioscopy in patients with unstable angina pectoris, N Engl J Med. 315:913 (1986).PubMedCrossRefGoogle Scholar
  10. 10.
    N.G. Pandian, A. Kreis, B. Brockway, J.M. Isner, A. Sacharoff, E. Boleza, R. Caro, and D. Muller, Ultrasound angioscopy: Real-time two- dimensional, intraluminal ultrasound imaging of blood vessel, Am J Cardiol 62:493–494 (1988).PubMedCrossRefGoogle Scholar
  11. 11.
    A.M. Lees, R.S. Lees, and F.J. Schoen, Imaging human atherosclerosis with Tc-99m-labeled low density lipoproteins. Arteriosclerosis 8:461–470 (1988).PubMedCrossRefGoogle Scholar
  12. 12.
    P.L. Ludmer, A.P. Selwyn, T.L. Shook, R.R. Wayne, G.H. Mudge, R.W. Alexander, and P. Ganz, Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries, N Engl J Med. 315:1046–1051 (1986).PubMedCrossRefGoogle Scholar
  13. 13.
    N.G. Pandian, Intravascular and intracardiac ultrasound imaging: An old concept, now on the road to reality. Circulation 80:1091–1094 (1989).PubMedCrossRefGoogle Scholar
  14. 14.
    S. Glagov, E. Weisenberg, C.K. Zarins, R. Stankunavicius, and G.J. Kolettis, Compensatory enlargement of human atherosclerotic coronary arteries, N Engl J Med. 316:1371–1375 (1987).PubMedCrossRefGoogle Scholar
  15. 15.
    B.N. Potkin, A.L. Bartorelli, J.M. Gessert, R.F. Neville, Y. Almagor, W.C. Roberts, and M.B. Leon, Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 81:1575–1585 (1990).PubMedCrossRefGoogle Scholar
  16. 16.
    J.A. Ambrose, S.L. Winters, and A. Stern, Angiographic morphology and the pathogenesis of unstable angina pectoris, J Am Coll Cardiol. 5:609–616 (1985).PubMedCrossRefGoogle Scholar
  17. 17.
    M.J. Davies, N. Woolf, P.M. Rowles, and J. Pepper, Morphology of the endothelium over atherosclerotic plaques in human coronary arteries, Br Heart J. 60:459–464 (1988).PubMedCrossRefGoogle Scholar
  18. 18.
    D.S. Berman, H. Kiat, J. Maddahi, and P.K. Shah, Radionuclide imaging of myocardial perfusion and viability in assessment of acute myocardial infarction, Am J Cardiol. 64:9B-16B (1989).PubMedCrossRefGoogle Scholar
  19. 19.
    G.A. Beller, Noninvasive assessment of myocardial salvage after coronary reperfusion: a perpetual quest of nuclear cardiology, J Am Coll Cardiol. 14:874–876 (1989).PubMedCrossRefGoogle Scholar
  20. 20.
    J.A. Leppo, and D.J. Meerdink, Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium, Circ Res. 65:632–639 (1989).PubMedGoogle Scholar
  21. 21.
    R. Beanlands, F. Dawood, W.H. Wen, P.R. McLaughlin, J. Butany, and P. Liu, Are the kinetics of technetium 99m-methoxy isobutyl isonitrile affected by cell metabolism and viability? Circulation (in press) (1990).Google Scholar
  22. 22.
    J.A. Leppo, and D.J. Meerdink, Comparative myocardial extraction of two technetium-laeled BATO derivatives (SQ30217,SQ32014) and thallium, J Nucl Med. 31:67–74 (1990).PubMedGoogle Scholar
  23. 23.
    R.K. Narra, A.D. Nunn, B.L. Kuczynski, T. Feld, P. Wedeking, and W.C. Eckelman, A neutral technetium-99m complex for myocardial imaging, J Nucl Med. 30:1830–1837 (1989).PubMedGoogle Scholar
  24. 24.
    D.W. Seldin, L.L. Johnson, D.K. Blood, M.J. Muschel, K.F. Smith, R.M. Wall, and P.J. Cannon, Myocardial perfusion imaging with technetium-99m SQ30217: Comparison with thallium-201 and coronary anatomy, J Nucl Med. 30:312–319 (1989).PubMedGoogle Scholar
  25. 25.
    A.P. Selwyn, K.M. Allen, A. L’Abbate, P. Horlock, P. Camici, J. Clark, H.A. O’Brien, and P.M. Grant, Relationship between regional myocardial uptake of Rb-82 and perfusion: Absolute reduction of cation uptake in ischemia, Am J Cardiol 50:112 (1982).PubMedCrossRefGoogle Scholar
  26. 26.
    H.R. Schelbert, M.E. Phelps, S.C. Huang, N.S. MacDonald, H. Husen, C. Selin, and D.E. Kuld, N-13 ammonia as an indicator of muyocardial blood flow. Circulation 63:1259 (1981).PubMedCrossRefGoogle Scholar
  27. 27.
    P.C. Albro, K.L. Gould, R.J. Westcott, G.W. Hamilton, J.L. Ritchie, and D.L. Williams, Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. Am J Cardiol. 42:751–760 (1978).PubMedCrossRefGoogle Scholar
  28. 28.
    E. DePasquale, A. Nody, G. DePuey, E. Garcia, G. Pilcher, C. Bredleau, G. Roubin, A. Gober, A. Gruentzig, P. D’Amato, and H. Berger, Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease. Circulation 77:316–327 (1988).PubMedCrossRefGoogle Scholar
  29. 29.
    D. Fell, J. Goodman, P.R. McLaughlin, L. Harris, S. Houle, M. Chin, B. Ross, R. Holloway, and P. Liu, Modification of silent and exercise induced ischemia by diltiazem in stable coronary disease. Circulation 78:326 (1988).Google Scholar
  30. 30.
    D.D. Miller, P. Liu, P.C. Block, H.W. Strauss, C.A. Boucher, and R.D. Okada, Prognostic value of exercise thallium imaging early after percutaneous transluminal coronary angioplasty (PTCA): quantitative and qualitative analysis, J Am Coll Cardiol 5:532 (1985).Google Scholar
  31. 31.
    D.D. Miller, P. Liu, H.W. Strauss, P.C. Block, R.D. Okada, and C.A. Boucher, Prognostic value of computer-quantitated exercise thallium imaging early after percutaneous transluminal coronary angioplasty, J Am Coll Cardiol 10:275–283 (1987).PubMedCrossRefGoogle Scholar
  32. 32.
    R.J. Gibbons, M.S. Verani, T. Behrenbeck, P.A. Pellikka, M.K. O’Connor, J.J. Mahmarian, J.H. Chesebro, and F.J. Wackers, Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 80:1277–1286 (1989).PubMedCrossRefGoogle Scholar
  33. 33.
    F.J. Wackers, R.J. Gibbons, M.S. Verani, D.S. Kayden, P.A. Pellikka, T. Behrenbeck, J.J. Mahmarian, and B.L. Zaret, Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy, J Am Coll Cardiol 14:861–873 (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Peter Liu
    • 1
  1. 1.University of TorontoTorontoCanada

Personalised recommendations